Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial
- Lancet Oncol., Available online 11 March 2016 | doi:10.1016/S1470-2045(15)00614-2
- 2016-03
- 의약학
- 한빛사논문, 상위피인용논문